Julie O'Neill
Overview
Julie O'Neill received an average of $5M in total compensation, including $549K in salary, at Alexion Pharmaceuticals from 2016 to 2018.
Source: SEC filing on March 26, 2019.
Related executives
We found six more executives who work or worked at Alexion Pharmaceuticals.
Ludwig Hantson
Alexion Pharmaceuticals
Chief Executive Officer
Paul Clancy
Alexion Pharmaceuticals
Chief Financial Officer
John Orloff
Alexion Pharmaceuticals
Executive Vice President, Head of Research and Development
Brian Goff
Alexion Pharmaceuticals
Executive Vice President, Chief Commercial and Global Operations Officer
Anne-Marie Law
Alexion Pharmaceuticals
Executive Vice President, Chief Human Experience Officer
Aradhana Sarin
Alexion Pharmaceuticals